Yahoo · Nov 5, 2026
Capital Group Global Growth (CGGO) Buys $51.3 Million More ICE on Nov. 3
The ETF added a new Intercontinental Exchange stake worth $51.3 million, part of $70.6 million in net buying across 51 increased positions.

NYSE · PM
Consumer Defensive · Tobacco
$211.28
Down-$4.21 (-1.99%)
Updated Nov 5, 2026, 4:20 PM
SID Score
7.3/10
Composite research score
Smart Money
58/100
Neutral
Price performance · PM
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 4, 2026
PM closed at $211.28 after 21 trading sessions, up 9.65% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 4, 2026 | $214.26 | $214.26 | $209.095 | $211.28 | 4.47M |
| Nov 3, 2026 | $206.45 | $209.16 | $205.06 | $208.03 | 3.25M |
| Nov 2, 2026 | $209.94 | $209.94 | $205.57 | $208.29 | 5.11M |
| Oct 30, 2026 | $212.67 | $214.35 | $208.02 | $208.79 | 4.59M |
| Oct 29, 2026 | $205.73 | $208.95 | $204.80 | $208.50 | 4.03M |
| Oct 28, 2026 | $202.27 | $203.89 | $200.60 | $202.64 | 3.34M |
| Oct 27, 2026 | $201.59 | $204.00 | $200.72 | $202.62 | 3.61M |
| Oct 26, 2026 | $199.81 | $203.71 | $199.615 | $201.87 | 5.04M |
| Oct 23, 2026 | $200.25 | $201.715 | $199.3123 | $199.47 | 3.58M |
| Oct 22, 2026 | $197.04 | $201.89 | $197.00 | $201.74 | 5.18M |
| Oct 21, 2026 | $187.14 | $197.83 | $184.00 | $197.46 | 5.79M |
| Oct 20, 2026 | $201.86 | $203.03 | $199.35 | $199.90 | 4.61M |
| Oct 19, 2026 | $202.14 | $203.20 | $200.89 | $201.05 | 4.87M |
| Oct 16, 2026 | $202.98 | $205.79 | $201.69 | $205.20 | 6.2M |
| Oct 15, 2026 | $210.00 | $210.45 | $199.53 | $199.90 | 7.97M |
| Oct 14, 2026 | $201.04 | $205.86 | $199.99 | $205.58 | 4.3M |
| Oct 13, 2026 | $202.87 | $203.00 | $199.26 | $199.29 | 4.44M |
| Oct 12, 2026 | $201.52 | $202.77 | $200.5001 | $202.00 | 3.53M |
| Oct 9, 2026 | $199.31 | $201.285 | $198.85 | $201.19 | 3.24M |
| Oct 8, 2026 | $194.84 | $202.6994 | $192.97 | $200.50 | 5.52M |
| Oct 7, 2026 | $191.51 | $192.87 | $190.385 | $192.69 | 3.94M |
The latest Smart Investors Daily articles mentioning PM.
Company
Market Activity
Research & News
PM research
Company profile and research snapshot.
Created from the international operations of Altria in 2008, Philip Morris International sells cigarettes and reduced-risk products, including heat sticks, vapes, and oral nicotine offerings, primarily outside of the US. With the 2023 acquisition of Swedish Match, a leading manufacturer of traditional oral tobacco products and nicotine pouches primarily in the US and Scandinavia, PMI is not only dominant in smokable products but also has the Iqos and Zyn brands, which respectively dominate heated tobacco and nicotine pouches in most markets.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Nov 3, 2026 | Stifel | Buy | — |
| Oct 26, 2026 | Argus Research | Buy | — |
| Oct 22, 2026 | Needham | Buy | — |
| Oct 22, 2026 | UBS | Neutral | — |
| Sep 23, 2026 | UBS | Neutral | — |
No generated briefing is available yet.
Yahoo · Nov 5, 2026
The ETF added a new Intercontinental Exchange stake worth $51.3 million, part of $70.6 million in net buying across 51 increased positions.
Yahoo · Nov 5, 2026
PARIS, November 05, 2026--The ISG AI Impact Summit will explore operating models and data and governance frameworks to scale AI, November 9–10 at the Pullman Paris Tour Eiffel.
Yahoo · Nov 3, 2026
Both tobacco giants beat earnings estimates, raised their dividends, and surged more than 30% this year, but they pull retirees in opposite directions when it comes to income now versus income later.
Benzinga · Nov 3, 2026
Stifel analyst Matthew Smith maintains Philip Morris Intl (NYSE:PM) with a Buy and raises the price target from $205 to $232.
Interpretive context generated from the platform’s current data sources.
Philip Morris International Inc. shares traded at $211.28, reflecting a single-day decline of 0.73%, per SID market data. Despite the near-term pullback, the stock has demonstrated strong momentum across multiple timeframes, gaining 10.97% over the past month, 12.35% over three months, and 33.04% over the trailing twelve-month period. The stock currently trades well above key moving averages, sitting 8.22% above its 50-day moving average of $195.22 and 15.82% above its 200-day moving average of $182.43, according to SID market data. The 14-day relative strength index registers at 67.3, approaching but not yet breaching overbought territory. Philip Morris carries a beta of 0.436, indicating substantially lower volatility relative to the broader market, consistent with its Consumer Defensive sector classification. The company's market capitalization stands at approximately $234.96 billion, with average daily trading volume of approximately 6.58 million shares.
Philip Morris International trades at a price-to-earnings ratio of 27.29, a premium relative to the broader Consumer Defensive sector, per SID market data. The PEG ratio stands at 5.76, suggesting the current earnings multiple is elevated relative to the company's projected growth rate. Notably, the company reports a negative price-to-book ratio of -21.53, according to SEC filings, which reflects a negative book value on the balance sheet — a structural characteristic resulting from years of accumulated share repurchases and significant leverage rather than operational distress. Philip Morris currently offers a dividend yield of 3.66%, providing a meaningful income component for shareholders. The combination of a high PEG ratio and premium P/E indicates that the market is pricing in factors beyond near-term earnings growth, potentially including the company's transition toward reduced-risk products such as IQOS and ZYN nicotine pouches, which represent longer-duration growth catalysts.
Philip Morris International registers a composite smart money score of 58 out of 100, generating a neutral signal overall, per SID market data. Institutional activity represents the strongest component, scoring a perfect 25 out of 25, indicating robust accumulation and sustained confidence among large fund managers. Congressional trading activity scores 12 out of 25, reflecting moderate engagement from lawmakers disclosed in public filings. Insider activity scores 12.5 out of 25, per SEC Form 4 filings, suggesting neither aggressive buying nor notable selling by company executives and directors. The dark pool component registers at 8.5 out of 25, indicating relatively limited activity in off-exchange venues. The divergence between the maximum institutional score and the below-average dark pool reading is notable; institutional investors appear to be building or maintaining positions through traditional exchange channels rather than seeking anonymity in alternative trading systems. The overall neutral signal suggests no strong directional conviction from aggregated smart money indicators.
Philip Morris International has demonstrated a consistent pattern of exceeding analyst expectations in its recent quarterly results. In its most recently reported quarter, the company posted earnings per share of $2.36 against a consensus estimate of $2.31, representing a positive surprise of $0.05, according to company earnings reports. The preceding quarter showed an even stronger beat, with actual EPS of $2.20 compared to the $2.05 estimate, delivering a $0.15 positive surprise. Looking ahead, analysts project EPS of $2.34 for the upcoming quarter and $2.05 for the following period, per analyst estimates. The sequential increase in estimates from $2.05 to $2.34 reflects expectations for continued earnings expansion. The company's ability to surpass estimates in consecutive quarters underscores operational execution and effective pricing strategies across its global portfolio. Investors will monitor whether the trend of positive earnings surprises continues as the company navigates evolving regulatory environments worldwide.
Wall Street coverage of Philip Morris International skews decidedly bullish, with the majority of recent ratings reaffirming buy recommendations. On November 3, 2026, Stifel reiterated its Buy rating on the stock, followed by Argus Research maintaining its Buy rating on October 26, per Wall Street analyst reports. Needham also reiterated a Buy rating on October 22. UBS represents the lone dissenter among recent coverage, maintaining a Neutral stance in both its October 22 and September 23 updates, according to SID consensus data. Notably, none of the five most recent analyst actions involved a downgrade or a shift to a negative outlook. The clustering of three Buy reiterations within a two-week window in late October suggests reinforced conviction following the company's earnings release. UBS's consistent Neutral positioning indicates a more cautious view on valuation or growth prospects relative to peers. The absence of any Sell ratings across recent coverage reflects broad institutional confidence in the company's strategic direction and financial trajectory.


The latest Smart Investors Daily articles mentioning PM.